Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subtherapeutic piracetam as a urinary adherence marker
NL-OMON53199Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of piracetam, sponsored by Netherlands Cancer Institute. Started Jul 2023; status: completed.
02
Drugs
piracetam
Beyond the preview
Go deeper on NL-OMON53199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53199.